Documented transboundary transmission of mpox between the Central African Republic and the Democratic Republic of the Congo

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

The project or effort depicted is sponsored by the Department of Defense Threat Reduction Agency. The content of the information does not necessarily reflect the position or the policy of the federal government, and no official endorsement should be inferred. This work was also supported by the International Mpox Research Consortium (IMReC) through funding from the Canadian Institutes of Health Research and International Development Research Centre (Grant No. 202209MRR-489062-MPX-CDAA-168421) and the Agence Francaise de Developpement through the PANAFPOX and AFROSCREEN project (grant agreement CZZ3209), coordinated by ANRS Maladies infectieuses emergentes in partnership with Institut de Recherche pour le Developpement (IRD). E.L. received a PhD grant from the French Foreign Office.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Ethics committee/IRB of the Ministry of Health, the Democratic Republic of the Congo, waived ethical approval for this work. All activities described were undertaken as part of regular public health surveillance conducted and approved directly by the Ministry of Health, Democratic Republic of the Congo, as well as partners from Central African Republic. Data was provided by the National Programme for Control of Mpox and Viral Haemorrhagic Fevers and the National Institute for Biomedical Research, the Democratic Republic of the Congo, as part of the case investigation performed within the South Ubangi Provincial Health Division. Patients consented orally to the collection of information and samples. Since the analyses conducted in this study were done retrospectively and the information and diagnostic samples were collected for surveillance and clinical care purposes, no written informed consent for research was provided by the patients

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes